Trevi Therapeutics, Inc.TRVINASDAQ
Loading
Other Income/Expenses (Net) Over TimeExpanding
Percentile Rank100
3Y CAGR+108.4%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+108.4%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
9x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $6.51M | +81.6% |
| 2024 | $3.58M | -25.8% |
| 2023 | $4.83M | +571.2% |
| 2022 | $719000.00 | +148.4% |
| 2021 | $-1.49M | -417.4% |
| 2020 | $-287000.00 | -149.7% |
| 2019 | $577000.00 | +125.5% |
| 2018 | $-2.26M | +51.4% |
| 2017 | $-4.65M | -88.2% |
| 2016 | $-2.47M | - |